Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00256529
Status:
COMPLETED
Last Update Posted:
2014-12-15
First Post:
2005-11-17
Brief Title:
Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia
Sponsor:
University of Utah
Organization:
University of Utah
Study Overview
Official Title:
Prospective Analysis of Eosinophilic Esophagitis in Patients Presenting With Dysphagia
Status:
COMPLETED
Status Verified Date:
2014-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a prospective descriptive cross sectional study to determine the percentage of patients presenting with dysphagia who are found to have eosinophilic esophagitis EoE and to establish which presenting factors warrant esophageal biopsies We hypothesize that a greater than expected percentage of patients who are biopsies will have histologic changes consistent with EE
Detailed Description:
All patients presenting with dysphagia who do not already carry a previous diagnosis for their dysphagia will be asked to enroll If patients have undergone previous work up for dysphagia such as manometry 24-hour probe or barium swallow they can still participate in this study Informed consent will take place prior to enrollment After patients present with dysphagia they will fill-out a questionnaire regarding their dysphagia symptoms An EGD with biopsies will then be performed Biopsies will be taken from 4 quadrants in the proximal and distal esophagus The distal esophagus biopsies will be taken 5 cm proximal to the Z-line Proximal biopsies will be taken anywhere proximal to 30 cm from the incisors
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None